NanoViricides Inc. (NNVC)

[robi-1-kenobi]

Such a partnership is likely required for progress on EbolaCide2, Nanopatent - although there may be a long shot backdoor per Leifsmith's hope for personal use by individual health care workers prior to traveling to Africa.

USAMRID and NIH would be ideal to enable following the regulatory required path to use of EbolaCide2:

Even in vitro efficacy testing requires a BSL4 facility.
And animal efficacy with primates requires further controls in a BSL4 facility.
And agreement on even the potential for abbreviated GLP animal Tox testing will need agreement by government agencies.

In this case, the hopes for emergency use of EbolaCide2 and the share price changes will go hand-in-hand.

A partnership announcement should result in a sharp pop in SP.
OTH no partnership announcements will continue the recent SP range and likely drift lower.